Drug Type Recombinant protein |
Synonyms- |
Target |
Action modulators |
Mechanism aFGF modulators(Fibroblast growth factor 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | United States | 15 Aug 2017 |